These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9068129)

  • 1. Analysis of the metabolites of [I-123] beta-CIT in plasma of human and nonhuman primates.
    Heinz A; Jones DW; Gorey JG; Knable MB; Lee KS; Saunders RC; Weinberger DR
    Synapse; 1997 Mar; 25(3):306-8. PubMed ID: 9068129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic metabolite of [123I]beta-CIT in human plasma may obstruct quantitation of the dopamine transporter.
    Bergström KA; Halldin C; Kuikka JT; Swahn CG; Tiihonen J; Hiltunen J; Länsimies E; Farde L
    Synapse; 1995 Apr; 19(4):297-300. PubMed ID: 7792723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study.
    Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N
    Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates.
    Heinz A; Higley JD; Gorey JG; Saunders RC; Jones DW; Hommer D; Zajicek K; Suomi SJ; Lesch KP; Weinberger DR; Linnoila M
    Am J Psychiatry; 1998 Aug; 155(8):1023-8. PubMed ID: 9699688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
    Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H
    Synapse; 1994 Feb; 16(2):93-103. PubMed ID: 8197578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
    Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
    J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain.
    Reneman L; Booij J; Lavalaye J; De Bruin K; De Wolff FA; Koopmans RP; Stoof JC; Den Heeten GJ
    Synapse; 1999 Oct; 34(1):77-80. PubMed ID: 10459174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [123I] beta-CIT, a tracer for dopamine and serotonin re-uptake sites: preparation and preliminary SPECT studies in humans.
    Bergström KA; Kuikka JT; Ahonen A; Vanninen E
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):128-31. PubMed ID: 7632756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and inactive enantiomers of 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: comparison using homogenate binding and single photon emission computed tomographic imaging.
    Scanley BE; Baldwin RM; Laruelle M; al-Tikriti MS; Zea-Ponce Y; Zoghbi S; Giddings SS; Charney DS; Hoffer PB; Wang S
    Mol Pharmacol; 1994 Jan; 45(1):136-41. PubMed ID: 8302272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified multidose preparation of iodine-123-beta-CIT: a marker for dopamine transporters.
    Zea-Ponce Y; Baldwin RM; Laruelle M; Wang S; Neumeyer JL; Innis RB
    J Nucl Med; 1995 Mar; 36(3):525-9. PubMed ID: 7884521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new iodinated tropane derivative (beta-CDIT) for in vivo dopamine transporter exploration: comparison with beta-CIT.
    Emond P; Chalon S; Garreau L; Dognon AM; Bodard S; Frangin Y; Baulieu JL; Besnard JC; Guilloteau D
    Synapse; 1997 May; 26(1):72-80. PubMed ID: 9097407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.
    Booij J; Andringa G; Rijks LJ; Vermeulen RJ; De Bruin K; Boer GJ; Janssen AG; Van Royen EA
    Synapse; 1997 Nov; 27(3):183-90. PubMed ID: 9329154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.
    Seibyl JP; Wallace E; Smith EO; Stabin M; Baldwin RM; Zoghbi S; Zea-Ponce Y; Gao Y; Zhang WY; Neumeyer JL
    J Nucl Med; 1994 May; 35(5):764-70. PubMed ID: 8176456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Baldwin RM; Zoghbi S; Zea-Ponce Y; Charney DS; van Dyck CH; Hoffer PB; Innis RB
    J Nucl Med; 1997 Sep; 38(9):1453-9. PubMed ID: 9293807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage.
    Heinz A; Saunders RC; Kolachana BS; Jones DW; Gorey JG; Bachevalier J; Weinberger DR
    Synapse; 1999 May; 32(2):71-9. PubMed ID: 10231127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
    Ishikawa T; Dhawan V; Kazumata K; Chaly T; Mandel F; Neumeyer J; Margouleff C; Babchyck B; Zanzi I; Eidelberg D
    J Nucl Med; 1996 Nov; 37(11):1760-5. PubMed ID: 8917170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.